// App-Quantinova.ai

P026/P026 : Treatment-Induced Reductions in Cerebrospinal Fluid Neurofilament Light Levels are Age-Dependent in Multiple Sclerosis

Researchers

Presenter

  • I. Smets

Principal Investigators

  • D. Holden

  • L. Bianchi

  • F. Ammoscato

  • B. Turner

  • M. Marta

  • K. Schmierer

  • G. Giovannoni

  • S. Gnanapavan

Medical Centers

  • QMUL - Blizard Institute, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • Cerebrospinal fluid

  • Neurofilament-light chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved